Skip to main content

Mireia del Toro Riera

I am a pediatrician, specialist in Pediatric Neurology and Coordinator of the Metabolic Unit. My activity focuses mainly on metabolic diseases, working to improve the diagnosis, treatment and quality of life of patients and their families. We participate in research in these group of diseases through different projects and clinical trials of advanced therapies. Since 2020 I coordinate the hospital's Rare Diseases program and its Commission. I also coordinate or participate in different external committees in the same field.

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca
Doctor
Paediatric Neurology
Children's Hospital and Woman's Hospital
Medical Coordinator
Rare diseases
Cross-departmental services

Mireia del Toro Riera

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca
Doctor
Paediatric Neurology
Children's Hospital and Woman's Hospital
Medical Coordinator
Rare diseases
Cross-departmental services

I am a pediatrician, specialist in Pediatric Neurology and Coordinator of the Metabolic Unit. My activity focuses mainly on metabolic diseases, working to improve the diagnosis, treatment and quality of life of patients and their families. We participate in research in these group of diseases through different projects and clinical trials of advanced therapies. Since 2020 I coordinate the hospital's Rare Diseases program and its Commission. I also coordinate or participate in different external committees in the same field.

I studied Medicine at the Autonomous University of Barcelona and did my Pediatrics residency at Vall d'Hebron University Hospital (1990-1994). It followed a specialization in Pediatric Neurology at the same hospital where I am consultant doctor since 1999.
In 2004 I began my specific dedication to metabolic diseases coordinating the unit that in 2012 was consolidated as a Spanish reference unit (CSUR) and later in Europe (ERN) and Catalonia (XUEC) and participates in the Neonatal Screening program of Catalonia. I currently coordinate the group of lysosomal diseases both in Metab-ERN and in AECOM (Spanish Association of Metabolic Diseases).
I participate in various research projects both collaborating with basic research groups and with registries and clinical trials of advanced therapies in metabolic diseases within the VHIR Pediatric Neurology research group.
Since 2020 I coordinate the hospital's rare diseases program and its commission. Our center is the public hospital that cares for the largest number of patients with these diseases in Catalonia and it is a challenge to work together to improve the experience and quality of life of patients and their environment as well as to maintain the level of expertise they deserve. In the same area I coordinate the PADEICS of rare diseases and participate in the Advisory Commission of the Department of Health.

Projects

Neurologia infantil

IP: Alfons Macaya Ruíz
Collaborators: Laia Ventura i Expósito, Belen Perez Dueñas, Laura Costa Comellas, Ainara Salazar Villacorta, Francina Munell Casadesus, Anna Marcé Grau, Miquel Raspall Chaure, Mireia del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián, Ana Laura Cazurro Gutierrez, David Gómez Andrés, Amaia Lasa Aranzasti, Lucy Dougherty de Miguel
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01171
Duration: 01/01/2022 - 30/06/2025

Evaluation of NGS candidate genes causality in developmental epileptic encephalopathiea

IP: Alfons Macaya Ruíz
Collaborators: Anna Marcé Grau, Miquel Raspall Chaure, Mireia del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI20/01803
Duration: 01/01/2021 - 31/12/2023

Enfermedades minoritarias causantes de degeneración de ganglios basales en pedriatría: implemementación combinada del análisis genómico y de biomarcadores.

IP: Belen Perez Dueñas
Collaborators: José Antonio Arranz Amo, Josefa Élida Vázquez Méndez, Alfons Macaya Ruíz, Anna Marcé Grau, Clara Carnicer Cáceres, Mireia del Toro Riera, Ana Felipe Rucián
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI18/01319
Duration: 01/01/2019 - 31/12/2022

Diagnostic and prognostic biomarkers in pediatric multiple sclerosis and related demyelinating disorders

IP: Mar Tintore Subirana
Collaborators: Cristina Auger Acosta, Alex Rovira Cañellas, Mireia del Toro Riera, Angela Vidal Jordana, Luciana Midaglia Fernandez, Georgina Arrambide García
Funding agency: Fundació La Marató de TV3
Funding: 100000
Reference: 20141831
Duration: 22/05/2015 - 22/11/2018

Related news

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

El 20% dels pacients en els quals s’havia trobat alguna predisposició genètica van ser diagnosticats amb algun tipus de tumor i van poder iniciar el tractament de manera precoç.

Related professionals

Marc Cabrera Hurtado

Marc Cabrera Hurtado

Research technician
Gene Therapy at Nervous System
Read more
Sheila Garcia  Prado

Sheila Garcia Prado

Psychiatry, Mental Health and Addictions
Read more
Pedro Serrano Pérez

Pedro Serrano Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Sara García González

Sara García González

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.